Ankylosing Spondylitis

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis [Phase 3]

  An open-label, multicenter long-term extension study evaluating etanercept in ankylosing spondylitis to assess long-term safety and efficacy…

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis [Phase 3]

  A Phase 3 study evaluating etanercept for ankylosing spondylitis has completed.

• CLINICAL_TRIALS trial_result · 2007-01-05
  Clinical Trial Update: Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis [Phase 3]

  A Phase 3 trial comparing etanercept 50 mg once weekly to 25 mg twice weekly in ankylosing spondylitis has completed.

• CLINICAL_TRIALS research · 2007-01-04
  Clinical Trial Update: Blocking Tumor Necrosis Factor in Ankylosing Spondylitis [Phase 2]

  A Phase 2 trial investigating blockade of tumor necrosis factor in ankylosing spondylitis has completed. This update notes completion but do…

• FDA approval · 2006-12-20
  FDA Approved: MELOXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)

  FDA approved the original ANDA for Meloxicam, manufactured by Unichem Pharmaceuticals (USA), Inc., introducing a generic version of the NSAI…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-12-19
  FDA Approved: DG HEALTH NAPROXEN SODIUM — Supplemental Application (Dolgencorp Inc)

  FDA approved a supplemental application for DG Health Naproxen Sodium (naproxen sodium) by Dolgencorp Inc. The action approves the generic p…

• FDA approval · 2006-12-08
  FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)

  FDA approved a supplemental application for infliximab submitted by Janssen Biotech, Inc.

• FDA approval · 2006-09-26
  FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)

  The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., updating the drug's labeling.

• CLINICAL_TRIALS trial_result · 2006-09-11
  Clinical Trial Update: Prednisolone in Active Ankylosing Spondylitis (AS) [Phase 2, Phase 3]

  A clinical trial update investigates prednisolone for active ankylosing spondylitis in Phase 2 and Phase 3; the current status of the trial …

• FDA approval · 2006-07-28
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…